Darren McGuire, MD
Enriched profileDistinguished Teaching Professor · University of Texas Southwestern Medical School
Darren McGuire is Distinguished Teaching Professor at University of Texas Southwestern Medical School. OpenAlex indexes 755 publications with 109,965 citations (h-index 117); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Cardiovascular Disease profiles in the FindMyKOL directory.
Data verified 13 Nov 2026
Overview
Updated 17 Nov 2026
Darren McGuire, MD, is Distinguished Teaching Professor at University of Texas Southwestern Medical School. The public record shows 755 publications with 109,965 citations (h-index 117), centered on Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Heart Failure Treatment and Management. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 33 companies, 1 NIH-funded awards (2005–2007).
- Most recent indexed publication: 2026 · European heart journal. Cardiovascular pharmacotherapy
- Top research focus: Diabetes Treatment and Management
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 33 companies
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 66 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 397.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Ad hoc consultant
FDA Cardiovascular and Renal Drugs Advisory Committee
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
Sponsor: University of Texas Southwestern Medical Center
Industry payments
Updated 13 Nov 2026
33 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year202510 payments$39,120openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20258 payments
- Lexicon Pharmaceuticals, Inc.Program year20257 payments
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Beta blocker34.4%Carvedilol100%Part D<11 patientsStatin28.1%Atorvastatin Calcium100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Nov 2026
1 NIH research award on record, funded 2005–2007 per NIH RePORTER. The latest:
- ROSIGLITAZONE VS PLACEBO: EFFECT OF CV PERFORMANCE AND MYOCARDIAL TRIGLYCERIDE
Ut Southwestern Medical Center
FY2007$13,052M01RR000633 - ROSIGLITAZONE VS PLACEBO: EFFECT OF CV PERFORMANCE AND MYOCARDIAL TRIGLYCERIDE
Ut Southwestern Medical Center
FY2006$108,043M01RR000633 - ROSIGLITAZONE VS PLACEBO: EFFECT OF CV PERFORMANCE AND MYOCARDIAL TRIGLYCERIDE
University of Texas Sw Med Ctr/dallas
FY2005$12,032M01RR000633
Congress activity
Updated 13 Nov 2026
84 congress contributions (2018–2026) across ADA, AHA, ASN, ENDO, ESC, IDSA per OpenAlex. The most recent:
- 1696-P: Effect of Semaglutide on COVID-19–Related Complications and All-Cause Death: Pooled Analyses of the SELECT, FLOW, and SOUL Trials
ADA Scientific Sessions
ADA2026Co-authorPoster - Ertugliflozin Effects on Cardiovascular, Kidney, and Inflammatory Biomarkers in VERTIS CV: Exploratory Analyses
ASN Kidney Week
ASN2026Co-author - 145-OR: ADA Presidents' Select Abstract: Association of Age at Type 1 Diabetes Diagnosis with Fatal Cardiovascular and Kidney Events
ADA Scientific Sessions
ADA2025Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 13 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- PharmaPlain: SOUL trial looking at the effect of oral semaglutide on cardiovascular outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease.
European heart journal. Cardiovascular pharmacotherapy
Article2026 - Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysis.
European journal of preventive cardiology
Article2026 - Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.
Diabetes care
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01Heart disease and stroke statistics--2015 update: a report from the American Heart Association.Article8,265 citations2015
- 02Heart Disease and Stroke Statistics—2016 UpdateArticle6,597 citations2015
- 03Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesArticle6,356 citations2018
- 04Heart Disease and Stroke Statistics—2015 UpdateArticle5,796 citations2014
- 05Heart Disease and Stroke Statistics—2014 UpdateArticle5,215 citations2013
Online presence
Updated 13 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Darren-Mcguire
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
cardiometabolichealth.org/faculty/darren-mcguire
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiometabolichealth.org ↗ - X / Twitter
Sandeep Das (@sandeepdasmd) on X congratulates Darren McGuire and colleagues on an updated SGLT2 inhibitor meta-analysis in JAMA Cardiology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗
- MD
Johns Hopkins University School of Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- Member
Alpha Omega Alpha Medical Honor Society
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Fellow
American Heart Association
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Fellow
American College of Cardiology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗ - Fellow
European Society of Cardiology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Former Chair
AHA Diabetes Committee
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Former member and present ad hoc consultant
FDA Cardiovascular and Renal Drugs Advisory Committee
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Deputy Editor
Circulation
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Senior Editor
Diabetes and Vascular Disease Research
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
Secondary affiliations
appointments beyond the home institution- Lead Physician
Parkland Health Outpatient Cardiology Clinic
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardionerds.com ↗
- PeerView Heart
Lung & Blood CME/CNE/CPE audio podcast episode (Translating Data Into Practice, weight loss pharmacotherapy and cardiovascular outcomes)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Video: Dr. Darren McGuire
Inside the Studio w/ Dr. Stephanie Coulter
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center